Synthesis and Antibacterial Evaluation of Silver-Coated Magnetic Iron Oxide/Activated Carbon Nanoparticles Derived from Hibiscus esculentus

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

The increasing prevalence of antimicrobial resistance alongside the pharmacological limitations and adverse effects associated with conventional antibiotics necessitates the development of novel and efficacious antimicrobial agents. In this study, magnetic iron oxide nanoparticles (MIONPs) were synthesized via a chemical co-precipitation method. Activated carbon (AC) derived from Hibiscus esculentus (HE) fruit was coated onto the nanoparticle surfaces to fabricate MIONPs/HEAC nanocomposites. To augment their antimicrobial properties, silver ions were chemically reduced and deposited onto the MIONPs/HEAC surface, yielding MIONPs/HEAC@Ag nanocomposites. Comprehensive characterization of the synthesized nanocomposites was performed using scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), vibrating sample magnetometry (VSM), dynamic light scattering (DLS), and zeta potential analysis. DLS measurements indicated average particle sizes of approximately 122 nm and 164 nm for MIONPs/HEAC and MIONPs/HEAC@Ag, respectively. Saturation magnetization values were determined to be 73.6 emu/g for MIONPs and 65.5 emu/g for MIONPs/HEAC. Antibacterial assays demonstrated that MIONPs/HEAC@Ag exhibited significant inhibitory effects against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923, with inhibition zone diameters of 11.50 mm and 13.00 mm, respectively. In contrast, uncoated MIONPs/HEAC showed negligible antibacterial activity against both bacterial strains. These findings indicate that MIONPs/HEAC@Ag nanocomposites possess considerable potential as antimicrobial agents for biomedical applications, particularly in addressing infections caused by antibiotic-resistant bacteria.

Article activity feed